|
PAFAH1B2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.42450000035255E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.07149999948464E-07 |
| Normal-vs-Stage2 |
5.299900E-02 |
| Normal-vs-Stage3 |
7.616500E-02 |
| Normal-vs-Stage4 |
3.50040000000051E-05 |
| Stage1-vs-Stage2 |
4.444800E-01 |
| Stage1-vs-Stage3 |
4.064800E-01 |
| Stage1-vs-Stage4 |
4.058800E-01 |
| Stage2-vs-Stage3 |
9.982200E-01 |
| Stage2-vs-Stage4 |
1.789040E-01 |
| Stage3-vs-Stage4 |
1.595200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51169999995648E-06 |
| Normal-vs-AfricanAmerican |
6.3703000000026E-05 |
| Normal-vs-Asian |
1.94197999999757E-05 |
| Caucasian-vs-AfricanAmerican |
7.921400E-01 |
| Caucasian-vs-Asian |
2.338400E-02 |
| AfricanAmerican-vs-Asian |
2.361800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.28820000222518E-08 |
| Normal-vs-Female |
1.459200E-01 |
| Male-vs-Female |
3.164600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.818850E-04 |
| Normal-vs-Extreme_Weight |
1.5081999982236E-08 |
| Normal-vs-Obese |
2.954000E-02 |
| Normal-vs-Extreme_Obese |
1.531990E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.208400E-01 |
| Normal_Weight-vs-Obese |
1.085640E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.218200E-01 |
| Extreme_Weight-vs-Obese |
7.383500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.004000E-01 |
| Obese-vs-Extreme_Obese |
2.453600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.044400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.152300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.93310000229374E-08 |
| Normal-vs-Age(81-100Yrs) |
4.69869999997208E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.618600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.838970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.042000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.390400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.308990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.037400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.32019999668998E-08 |
| Normal-VS-Type2 PRCC |
4.48450000000156E-05 |
| Normal-VS-KIRP CIMP |
6.815800E-01 |
| Normal-VS-Unclassified PRCC |
2.371000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.828200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.938300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.106400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.312810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.054200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.977400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.90099999963778E-07 |
| Normal-vs-N1 |
6.376000E-02 |
| Normal-vs-N2 |
3.379600E-03 |
| N0-vs-N1 |
2.998800E-01 |
| N0-vs-N2 |
8.095400E-01 |
| N1-vs-N2 |
5.470800E-01 |
|
|
